The Emerging Roles of circFOXO3 in Cancer

Dean Rao1,2, Chengpeng Yu1,2, Jiaqi Sheng1,2

  • 1Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

Circular RNAs (circRNAs) are stable molecules involved in cancer. CircRNA Forkhead box O3 (circFOXO3) shows abnormal expression in various cancers, acting as a molecular sponge, but its full functions require further research.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are non-coding RNAs formed by mRNA reverse splicing.
  • Their unique structure confers stability, making them resistant to degradation.
  • CircRNAs are tissue-specific and play roles in various diseases, particularly cancer.

Purpose of the Study:

  • To review the roles and molecular mechanisms of circRNA Forkhead box O3 (circFOXO3) in cancer.
  • To summarize the involvement of circFOXO3 and its target genes in diverse cancer types.
  • To highlight the need for further research into the multifaceted functions of circFOXO3.

Main Methods:

  • Literature review of studies on circFOXO3 in various cancers.
  • Analysis of circFOXO3's role as a molecular sponge.
  • Discussion of circFOXO3's impact on cancer proliferation, invasion, and prognosis.

Main Results:

  • CircFOXO3 is abnormally expressed in multiple cancers, including prostate, liver, brain, bladder, and breast cancers.
  • CircFOXO3 functions as a molecular sponge, influencing cancer development.
  • The precise roles and mechanisms of circFOXO3 in cancer are not fully elucidated.

Conclusions:

  • CircFOXO3 is implicated in the progression of various cancers.
  • Understanding circFOXO3's molecular mechanisms can enhance cancer research.
  • Further investigation is crucial to fully comprehend circFOXO3's diverse functions in oncology.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K